Extracellular vesicles in COVID-19 and long COVID: Structural mediators of viral persistence and immune dysfunction.
Current opinion in structural biology·
- DOI
- 10.1016/j.sbi.2026.103375
- PMID
- 42641338
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- Publisher unavailable
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The article may inform research prioritization around extracellular-vesicle characterization, biomarker development, and therapeutic-platform evaluation for COVID-19 and long COVID. The supplied abstract does not establish clinical effectiveness, population-level impact, or readiness for public-health implementation.
Structured evidence summary
Research question
The review examines how extracellular vesicles may relate to viral antigen persistence, immune dysregulation, neuro-immune signaling, and vascular injury in COVID-19 and long COVID, and considers their possible use as biomarkers or therapeutic platforms.
Study design
This is a narrative review synthesizing current insights and evaluating potential applications of extracellular vesicles. The supplied abstract does not describe a primary cohort, intervention, or systematic-review method.
Population and setting
The review concerns extracellular vesicles associated with SARS-CoV-2 infection, COVID-19, and long COVID. No specific participant population, clinical setting, sample size, or geographic setting is provided.
Main findings
The review describes extracellular vesicles as structured carriers of viral and host-derived material and discusses advanced single-particle methods for assessing vesicle heterogeneity and nanomechanical properties. It identifies potential diagnostic and therapeutic applications while emphasizing the need for standardized structural characterization.
Public-health relevance
The article may inform research prioritization around extracellular-vesicle characterization, biomarker development, and therapeutic-platform evaluation for COVID-19 and long COVID. The supplied abstract does not establish clinical effectiveness, population-level impact, or readiness for public-health implementation.
Important limitations
The supplied evidence is a single review abstract and bibliographic record, without the full text, search methods, source-study details, quantitative results, or explicit review limitations. The abstract itself indicates that standardized structural characterization remains needed, so the paper requires full-text assessment for decision-grade interpretation.
GIDS interpretation
The article is discoverable in the supplied metadata under COVID-19-related diagnostics and treatment topics and provides context on extracellular-vesicle research. It does not provide evidence that any live surveillance signal is confirmed or explained.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.